美国中毒中心钠通道阻滞剂中毒治疗推荐现状调查
该横断面调查匿名询问美国中毒中心医疗主任对钠通道阻滞剂中毒的初始治疗推荐、碳酸氢钠推荐标准与阈值,以及特定药物暴露对推荐的影响。30名受访者(60%)完成调查。仅心电图改变时,碳酸氢钠是最常推荐的初始治疗(23人,78%);仅低血压时最常推荐血管升压药(17人,57%);仅中枢神经系统毒性时最常推荐单纯支持治疗(28人,93%)。心电图改变、休克和中枢神经系统毒性并存时,28人(93%)推荐碳酸氢钠作为初始治疗。推荐碳酸氢钠的QRS阈值中位数为120毫秒(IQR 100-160),高于既往调查的100毫秒(P=0.002);基线中毒前QRS 130毫秒时阈值增至140毫秒(IQR 130-160)(P<0.001)。43.3%受访者在安非他酮中毒时较少推荐碳酸氢钠。作者结论认为需进一步研究评估钠通道阻滞剂中毒的最佳处理策略。
要点
- 心电图改变、休克和中枢神经系统毒性并存时,93%(28/30)受访者推荐碳酸氢钠作为初始治疗。
- 仅心电图改变时,78%(23/30)推荐碳酸氢钠作为初始治疗。
- 仅低血压时,57%(17/30)推荐血管升压药作为初始治疗;仅中枢神经系统毒性时,93%(28/30)推荐单纯支持治疗。
- 碳酸氢钠推荐的QRS阈值中位数为120毫秒(IQR 100-160),高于1997年调查的100毫秒(P=0.002)。
- 基线中毒前QRS 130毫秒时,推荐碳酸氢钠的阈值增至140毫秒(IQR 130-160)(P<0.001);43.3%受访者在安非他酮中毒时较少推荐碳酸氢钠。
适用人群与场景
- 美国中毒中心医疗主任,作为受访者对钠通道阻滞剂药物中毒的治疗推荐提供匿名回答。
诊断标准与关键阈值
- 97%(29/30)受访者在推荐碳酸氢钠时考虑QRS时限。
- 推荐碳酸氢钠的QRS阈值中位数为120毫秒(IQR 100-160)。
- 基线中毒前QRS时限为130毫秒时,推荐碳酸氢钠的阈值中位数增至140毫秒(IQR 130-160)。
处置流程与药物剂量
- 仅心电图改变时,最常推荐的初始治疗为碳酸氢钠(23/30,78%)。
- 仅低血压时,最常推荐的初始治疗为血管升压药(17/30,57%)。
- 仅中枢神经系统毒性时,最常推荐的初始治疗为单纯支持治疗(28/30,93%)。
- 心电图改变、休克和中枢神经系统毒性并存时,28/30(93%)推荐碳酸氢钠作为初始治疗。
- 第二线和第三线治疗最常推荐血管升压药(21/30,70%)和高渗盐水(11/30,37%)。
- 43.3%受访者在安非他酮中毒时较少推荐碳酸氢钠。
研究设计与关键结果
- 研究类型为横断面调查,发放55份问卷,30份完成(60%)。
- 碳酸氢钠是仅心电图改变时最常推荐的初始治疗(23/30,78%)。
- 仅低血压时最常推荐血管升压药(17/30,57%);仅中枢神经系统毒性时最常推荐单纯支持治疗(28/30,93%)。
- 心电图改变、休克和中枢神经系统毒性并存时,28/30(93%)推荐碳酸氢钠作为初始治疗。
- 第二线和第三线治疗最常推荐血管升压药(21/30,70%)和高渗盐水(11/30,37%)。
- 推荐碳酸氢钠的QRS阈值中位数为120毫秒(IQR 100-160),高于1997年调查的100毫秒(P=0.002)。
- 基线中毒前QRS 130毫秒时,阈值增至140毫秒(IQR 130-160)(P<0.001)。
- 43.3%受访者在安非他酮中毒时较少推荐碳酸氢钠。
证据类型、等级与局限
- 证据类型:横断面调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该调查显示,当前美国中毒中心医疗主任推荐碳酸氢钠的QRS阈值中位数为120毫秒,高于1997年调查的100毫秒,且基线QRS延长时阈值提高至140毫秒。
- 合并心电图改变、休克和中枢神经系统毒性时,多数受访者推荐碳酸氢钠作为初始治疗,而非单纯支持治疗。
- 安非他酮中毒时,部分受访者较少推荐碳酸氢钠。
- 作者认为需进一步研究评估钠通道阻滞剂中毒的最佳处理策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: A 1997 survey assessed United States poison center medical directors' recommendations for serum alkalinization in tricyclic antidepressant poisoning. This study aims to assess current recommendations for all sodium channel blocking drug poisonings.
METHODS: This was a cross-sectional survey utilizing anonymous responses from United States poison center medical directors. Participants were asked about initial treatments of varying features of sodium channel blocking drug poisoning, criteria and thresholds to recommend sodium bicarbonate, including a patient with baseline pre-poisoning QRS prolongation; and how specific drug exposures influenced treatment recommendations. The QRS duration thresholds to recommend sodium bicarbonate were compared to those from the prior survey and to the case with pre-poisoning QRS prolongation.
RESULTS: Of 55 recipients, 30 (60%) surveys were completed. Sodium bicarbonate was the most frequently recommended initial treatment (23 participants, 78%) for isolated electrocardiogram changes. Vasopressors and supportive care alone were the most frequent initial recommendations for isolated hypotension (17, 57%) and isolated central nervous system toxicity (28, 93%), respectively. In the presence of electrocardiogram changes, shock, and central nervous system toxicity, 28 (93%) recommended sodium bicarbonate as initial treatment. The most frequent second- and third-line treatments were vasopressors (21, 70%) and hypertonic saline (11, 37%). Twenty-nine (97%) participants considered QRS duration when recommending sodium bicarbonate. The median QRS threshold utilized was 120 (IQR 100-160) milliseconds, compared to the previous survey's median threshold of 100 milliseconds (P = 0.002). In the case with pre-poisoning QRS duration 130 milliseconds, this threshold increased to 140 (IQR 130-160) milliseconds (P <0.001). Thirteen (43.3%) respondents were less likely to recommend sodium bicarbonate in bupropion poisoning.
DISCUSSION: The threshold QRS duration for recommending sodium bicarbonate was greater in 2024 compared to 1997, likely due to practice changes and increased variety of sodium channel blocking drugs.
CONCLUSIONS: Sodium bicarbonate recommendations continue to focus heavily on electrocardiogram changes, with exact thresholds depending on patient and drug exposure factors. Further studies are needed to evaluate the optimal approach to sodium channel blocking drug poisoning.
参考来源
- Simpson MD, Johnson L, Burns MM, et al. Contemporary survey of United States poison center treatment recommendations for sodium channel blocking drug poisoning. Clin Toxicol (Phila). 2026. PMID: 42370555. doi:10.1080/15563650.2026.2688241
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。